Secukinumab for patients failing previous tumour necrosis factor-α inhibitor therapy: results of a randomized open-label study (SIGNATURE)
Warren, R. B., Barker, J. N. W. B., Finlay, A. Y., Burden, A. D., Kirby, B., Armendariz, Y., Williams, R., Hatchard, C., Khare, S. & Griffiths, C. E. M., 1 Jan 2019, In: British Journal of Dermatology.
Research output: Contribution to journal › Article › peer-review